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This paper provides a consolidated overview of public and healthcare professionals’ attitudes towards
vaccination in Europe by bringing together for the ﬁrst time evidence across various vaccines, countries
and populations. The paper relies on an extensive review of empirical literature published in English
after 2009, as well as an analysis of unpublished market research data from member companies of
Vaccines Europe. Our synthesis suggests that hesitant attitudes to vaccination are prevalent and may be
increasing since the inﬂuenza pandemic of 2009. We deﬁne hesitancy as an expression of concern or
doubt about the value or safety of vaccination. This means that hesitant attitudes are not conﬁned only to
those who refuse vaccination or those who encourage others to refuse vaccination. For many people,
vaccination attitudes are shaped not just by healthcare professionals but also by an array of other in-
formation sources, including online and social media sources. We ﬁnd that healthcare professionals
report increasing challenges to building a trustful relationship with patients, through which they might
otherwise allay concerns and reassure hesitant patients. We also ﬁnd a range of reasons for vaccination
attitudes, only some of which can be characterised as being related to lack of awareness or misinfor-
mation. Reasons that relate to issues of mistrust are cited more commonly in the literature than reasons
that relate to information deﬁcit. The importance of trust in the institutions involved with vaccination is
discussed in terms of implications for researchers and policy-makers; we suggest that rebuilding this
trust is a multi-stakeholder problem requiring a co-ordinated strategy.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Vaccines are widely recognised by health authorities and the
medical community as a major tool for achieving public health
successes such as the eradication of smallpox (Andre et al., 2008;
ECDC, 2012). Yet, for many individuals, this is not a sufﬁcient ba-
sis with which to embrace vaccination whole-heartedly. They
doubt the beneﬁts of vaccines, worry over their safety and question
the need for them, an attitude we refer to as vaccine hesitancy. An
attitude of hesitancy differs from an action of vaccine refusal. Even
those who are vaccinated can harbour hesitancy towards certain
aspects of vaccination.
The policy concern is that hesitancy soon becomes refusal, as
suggested by theory and experience (Salathé and Bonhoeffer,
2008), and unvaccinated clusters emerge in which disease out-
breaks can occur (Gangarosa et al., 1998; Jansen et al., 2003). Forr Ltd. This is an open access articleexample, a UK study of 14,578 children found that three-quarters of
parents whose children were not vaccinated with MMR made a
conscious decision to not vaccinate (Pearce et al., 2008). The refusal
rate suggests that the traditional assumption that parents suffer
information deﬁcit, lack access to the facts or are misinformed is, at
best, an incomplete understanding of vaccination attitudes
(Hobson-West, 2003). We assume that, at one point, these parents
were hesitant before they made their decision, and so there is an
important distinction to be drawn between hesitancy and outright
rejection.
If we take the distinction between hesitancy and rejection
seriously, it becomes clear that whilst coverage rates are helpful for
identifying those who reject, the metric does little to help us un-
derstand hesitant attitudes, their origins and the scope to change
them. The goal of maintaining high coverage rates helps to ensure
vaccination beneﬁts are delivered widely, but the very act of
delivering wide scale vaccination can make vaccines ‘victims of
their own success’. As the ravages of disease become less familiar to
people, it may become more challenging to articulate the desir-
ability of vaccination. Nichter (1995: p 617, 625) distinguishedunder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. Method ﬂow-chart.
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need for vaccination) and ‘passive acceptance’ (vaccination denoting
compliance or yielding to power). Nichter (1995: p 625) pointed
out that “demand is often low, even among populations having
impressive immunisation rates”. When hesitancy is prevalent,
ensuring compliance and high coverage rates may not be enough to
ensure that vaccination is sustainable in the future (Roalkvam et al.,
2013: p 192). Closer examination is needed of what is required for
the development of active demand.
The central concepts for cultivating active demand are trust and
legitimacy (as set out in Roalkvam et al., 2013). By trust, we mean
the ability to rely on somebody else’s claims about a situation, and
by legitimacy we mean the grounds upon which policymakers
make decisions (O’Neill, 2002). When trust and legitimacy are
lacking, many feel the need to re-interpret information about
vaccination. Such re-interpretation can be elaborate: for example,
some distinguish between ‘natural immunity’ and ‘artiﬁcial im-
munity’ induced through vaccination, and some believe a child’s
immune system can become ‘overloaded’ (Leach and Fairhead,
2007: p 52e55). The speciﬁcs of such re-interpretations are often
localised and historically dependent: for example, the autism
claims implicating the MMR vaccine were mostly a UK phenome-
non, and the multiple sclerosis claims implicating the HepB vaccine
were mostly a French phenomenon.
Trust and legitimacy are crucial concepts for understanding why
some sources of information on vaccination are consulted more
than others, how information on vaccination is re-interpreted and
how beliefs that are often contrary to medical science are formed
(as in the examples above). They help to explain some of the puz-
zles thrown up by coverage rates, such as why the better educated
(who mistrust) might reject vaccination more readily than the less
educated (who accept passively) (Hak et al., 2005).
Concern about the trust in, and legitimacy of, institutions
involved with vaccination has again come to the fore following the
H1N1 inﬂuenza ‘pandemic’ that never arrived (Allam, 2009;
Scoones, 2010). Claims that the ‘pandemic’ response may have
been improperly inﬂuenced by commercial interests (Flynn, 2010;
Godlee, 2010; Epstein, 2011) coincided with evidence of increas-
ingly hesitant attitudes to vaccination (Sypsa et al., 2009; Poland,
2010; Chanel et al., 2011). The WHO Director-General said about
H1N1: “we did not anticipate that people would decide not to be
vaccinated. In today’s world, people can draw on a vast range of
information sources. People make their own decisions about what
information to trust, and base their actions on those decisions”
(Chan, 2010). Some policymakers were clearly surprised to discover
that their organisations did not command the trust they expected
when they recommended vaccination.
The erosion of public trust in institutions involved with vacci-
nation could be related to broader social trends (Blume, 2006;
Hobson-West, 2007; Poltorak et al., 2005). For scholars such as
Hobson-West (2003), public health authorities issuing vaccination
recommendations struggle to resonate with a general public who
are now more enamoured with notions of individual empower-
ment and exercising patient-choice. For scholars such as Blume,
public health narratives are undermined by multiple stakeholders
in multiple ways; for example, by the creation of markets where
individual health consumers are expected to exercise purchasing
power (Blume, 2006) and by the pressure to conform to the
standardised products of global vaccine producers (Blume and
Zanders, 2006). Another example might be the way in which
many stakeholders now strive for personalised medicine empha-
sising personal characteristics (rather than the community char-
acteristics that public health would) (Hedgecoe, 2004). Individuals,
governments, researchers, companies and health services are all
responsible for such public health narratives.What follows then is a review with an agenda that centres on
attitudes to vaccination, and one that seeks to determine whether
vaccine hesitancy is a prevalent phenomenon, what the reasons are
for hesitancy, and what might constitute a basis for cultivating
active demand. A number of recent reviews cover attitudes to
vaccination. A US Centers for Disease Control review focused on
parental perceptions but not those of healthcare professionals
(Kennedy et al., 2011). A Canadian Institute of Health Research
systematic review also focused only on parental beliefs (Mills et al.,
2005); moreover, they excluded vaccine-speciﬁc papers, which we
believe can be quite important. A European Centre for Disease
Prevention and Control (ECDC) systematic review focused on what
constitutes effective communication regarding vaccination, as
opposed to explaining reported attitudes (Cairns et al., 2012). There
are also at least 3 recent reviews (Allen et al., 2010; Brown et al.,
2010; Hofmann et al., 2006) focussing on speciﬁc vaccines and/or
populations (HPV, Inﬂuenza-health professionals and MMR-
parents, respectively) which we hope to complement.
We aim tomake three distinct contributions to this literature. As
far as we are aware, we provide the ﬁrst consolidated overview of
vaccination attitudes (deﬁned here as expressions of support or
hesitancy) among public and healthcare professionals across
different vaccines and countries in Europe. Secondly, we provide an
extensive mapping of the empirical literature (mostly surveys) on
attitudes to vaccination in Europe in the ‘post-pandemic’ period
(2009e2012). Thirdly, the paper offers an analysis of unpublished
market research data frommember-companies of Vaccines Europe,
and compares this with published literature.2. A review of 2009e2012 literature
2.1. Review methodology
The literature containing European data was reviewed system-
atically in a multi-step process (Fig. 1) conducted in the UK. English
language articles from 2009 until August 2012 were searched in
PubMed, Embase, Cochrane and Web of Science databases. Search
terms included immunisation, perceptions, and attitudes (full
search string available on request). Expert knowledge of the liter-
ature, snowballing and Google searches were also used and
exclusion criteria applied (Appendix 1) to derive the ﬁnal set of
articles for full review (Appendix 2).
The papers we reviewed contained a range of self-reported
determinants of vaccination attitudes. During our review, we
searched for reasons that were cited for attitudes of hesitancy and
support. We then categorised reasons that were very similar so that
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tudes of hesitancy/support. The frequency with which these kinds
of reasons were cited in the literature we reviewed is reported in
the ﬁgures below and referred to in the text below.
We also organised the papers according to: country of data
collection, methodology, type of vaccine (HPV, inﬂuenza etc.) and
population studied (adults, healthcare professionals, students,
children etc). This helped to map the overall landscape of the
literature.
The study did not collect any primary data, and no data was
collected from human subjects directly by the authors. Even so, the
authors sought (and acquired) approval from RAND Europe’s
Quality Assurance team and ethical review.
2.2. Review results
1187 articles were initially retrieved for review. Title and ab-
stract review, and selection of post-2009 data only, resulted in 50
papers. Of these, 10 were irrelevant and 2 were unavailable e
leaving 38 papers for full-text review. Quality criteriawere not used
since all the papers met prior standards set by the peer-reviewed
publication process.
15 countries are represented in the full text review (Fig. 2). There
is a paucity of papers from Eastern Europe, though this may simply
be an artefact of excluding non-English language papers. The
literature is primarily a qualitative gathering of self-reported de-
terminants, with questionnaires the dominant methodology (26
papers), and some using focus groups (5 papers) and interviews (5
papers). Almost a quarter of papers discuss attitudes to vaccination
in general but the majority examines attitudes with respect to
speciﬁc vaccines. Over a third of papers examined attitudes to HPV
vaccination, and nearly a quarter examined attitudes to seasonal-
inﬂuenza vaccination. There were almost twice as many papers
about the general population than about healthcare professionals
(general population included adults and students of varying ages).
In the sub-sections that follow, we present reasons underlying
vaccination attitudes by population group, where the general
population includes non-medical students and children and the
healthcare population includes a range of professionals (medical
students, general practitioners, dentists, midwives, nurses and
physicians of varying specialties such as rheumatology). Figs. 3e5
show a count of how often each reason appeared in our reviewed
papers. There is no weighting to adjust for importance (signiﬁcance
of the reasons is discussed in relation to wider literature in Section
4). The ﬁgures show the range of reasons underlying vaccination
attitudes across vaccines and countries.Fig. 2. Countries represented in the review (multi-country papers are ‘multi-counted’).2.2.1. General population (24 papers)
Themost commonly cited reason for general population support
for vaccination is healthcare professionals’ advice, although this
category also includes the often false belief that vaccination is
mandatory (mandatory vaccination is quite rare, see Haverkate
et al. (2012)). Self-protection may be overestimated here because
all nine of the citations in this category come from only three pa-
pers, with a single paper (Forster et al., 2012) being responsible for
six of the citations (i.e. Forster et al.’s data offered six reasons that
were all slight variations on the theme of self-protectione thus, we
say that self-protection was cited six times, and nine times if we
include the two other papers). Advice from friends, family or col-
leagues is cited more than awareness of illness and vaccination as a
reason for support.
Unsurprisingly, the most commonly cited reason for general
population hesitancy towards vaccination is safety concerns. Lack
of awareness, low perceived severity of illness and a belief in
alternative medicine were often cited as reasons for hesitancy.
However, lack of knowledge was mentioned less than distrust of
government sources. One paper also noted a lack of importance
placed on GP’s recommendations, and another noted distrust of
pharmaceutical companies. Two hesitancy reasons are speciﬁc to
HPV vaccination. The ‘other’ category encompasses reasons which
were only cited once across all of the papers e including ‘choice
restriction’ and ‘too much choice in vaccines’ revealing the exis-
tence of directly opposing views. Reasons cited under ‘Fear of
needles’ varied in signiﬁcance across the papers, from being the
primary reason for the avoidance of vaccination (Forster et al.,
2012) to being cited by only a few study participants (Prymula
et al., 2012).
2.2.2. Healthcare professionals (patient-vaccinating) (4 papers)
A belief in the beneﬁts of vaccines and a sense of duty to pro-
mote health and vaccination are the primary reasons for healthcare
workers recommending vaccines to their patients. One study
showed that a trustful doctorepatient relationship is necessary to
recommend vaccines to patients, which is listed here under the
term practicalities (see next paragraph for other reasons entered
under the term). Two of the four papers reviewed here (Gottvall
et al., 2011; Oscarsson et al., 2011) speciﬁcally relate to HPV. More
generally, three of the four papers noted lack of time when dis-
cussing vaccines with patients.
2.2.3. Healthcare professionals (self-vaccinating) (10 papers)
The most commonly cited reasons underlying healthcare pro-
fessionals’ self-vaccination were to protect patients, themselves
and non-patients (e.g. family). Three sentiments were classiﬁed
under the reason ‘practicalities’: workplace vaccination, free
vaccination and vaccination to avoid absenteeism. The third
sentiment reveals an assumption: in order to believe a vaccine will
help avoid absenteeism, there needs to be an appreciation for the
possibility of contracting illness and an acknowledgement of its
potential severity. So, the sentiment indicates that healthcare
professionals have this kind of appreciation for vaccination.
The most commonly cited reason for healthcare professional
hesitancy towards self-vaccination is safety concerns. A lack of
vaccine knowledge is also revealed through a number of senti-
ments, widely regarded as false and unsubstantiated, which
included: the belief that pregnancy is a contraindication for the
pandemic-inﬂuenza vaccine, the belief that vaccines contain
dangerous additives and promote allergies, and the belief that the
seasonal-inﬂuenza vaccine also protects against pandemic-
inﬂuenza. In addition, a lack of awareness about national guide-
lines or recommendations was categorised under this reason. As
such, lack of knowledge remains an important reason for hesitancy.
Fig. 3. General population’s reasons for vaccination attitudes and the number of times such kinds of reasons are cited in the literature we reviewed.
Fig. 4. Patient-vaccinating healthcare professionals’ attitudes and their citation frequency.
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Fig. 5. Self-vaccinating healthcare professionals’ attitudes and their citation frequency.
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and the belief that one’s own vaccination does not beneﬁt patients
e a reason which could have been classiﬁed under lack of concern
or lack of knowledge.
3. Market research data
3.1. Data acquisition and methodology
Unpublished market research data was provided to authors by
Vaccines Europe member-companies under conﬁdentiality agree-
ments. Data was included only if study methods were available for
review by the research team. Editorial and analytical control
remained with authors (OY and SCC) throughout the analysis.
3.2. Market research results
Six datasets were included, all of which collected data after
2009, using a mix of survey, focus groups and interview across
multiple European countries. Datasets focused on perceptions of
vaccination, sources of vaccination information, and changes in
attitudes over time. One dataset was excluded for not reporting
methods explicitly; ﬁve were reviewed in full:
 Dataset 1: 4015 adults surveyed across Germany, UK, France and
Spain.
 Dataset 2: 1000 adults surveyed across UK.
 Dataset 3: 800 GPs surveyed across Germany, UK, France and
Spain.
 Dataset 4: 80 healthcare professionals interviewed across Ger-
many, Italy, France and Spain. Dataset 5: 130 physicians and patients interviewed across
France, Spain, Italy, Germany and UK.
Major ﬁndings from the datasets are reported below, with some
details presented in Figs. 6, 7.
3.2.1. General population and healthcare professionals (Datasets 1e
4)
Vaccination was one of the three most desired public health
outcomes for 41% (only healthcare provision and sanitation
featured more strongly) (Dataset 2). A majority (>95%) of GPs
agreed that vaccination is ‘the best way to protect populations’ and
‘truly a major asset’. However, GPs also agreed with a number of
propositions that should concern policymakers. 63% feel they have
to contend with more sceptical patients than they did a few years
ago, 90% want better patient campaigns, 57% feel there is not
enough support from government (Dataset 3).
Healthcare professionals were found to have altruistic views of
vaccination (Dataset 4). Their focus is on protecting their patients
and sometimes the public community. They tend not to consider
themselves as needing vaccination, seeing themselves as strong
and healthy in comparison to their patients. For healthcare pro-
fessionals, practical issues (such as convenience) do not seem to be
as signiﬁcant a barrier as their perceived lack of need for vaccina-
tion, especially in Spain and Italy (Dataset 4).
3.2.2. Patientephysician interaction (Dataset 5)
65 mock (i.e. simulated) consultations between a physician and
a patient were conducted (Dataset 5). Physicians’ behaviour was
examined in response to different types of patients, and then
classiﬁed as assertive or unassertive (Fig. 7).
Fig. 6. Summarised details from datasets 1e4 on attitudes to vaccination.
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hesitant patients depended on whether patients were ‘non-
informed’, ‘passively informed’ or ‘pro-actively misinformed’.
However, the dataset also revealed that the ability to persuade
hesitant patients depended on whether physicians were ‘assertive’
or ‘unassertive’. Unassertive physicians were easily perturbed by
their environment (such as a media scare), whilst assertive physi-
cians carried a stable belief in the value of vaccination. Unassertive-
physicians and hesitant-patient interactions were shaped strongly
by forces beyond the individuals present in the consultation room
(Dataset 5).
4. Discussion
4.1. The general population exhibits high levels of hesitancy and
multiple forms of distrust
A number of ﬁndings about the general population emerge from
our review of the literature andmarket research data. First, hesitantFig. 7. Patient-physicattitudes are prevalent in empirical studies and datasets. Hesitancy
is not a rare phenomenon or conﬁned solely to ‘anti-vacci-
nationists’; it includes people who have not yet rejected vaccina-
tion. Focussing on only vaccine uptake rates and neglecting
underlying attitudes is likely to underestimate the challenge of
maintaining vaccination coverage in the future.
Second, a wide variety of reasons were reported for vaccination
attitudes, few of which relate to a lack of awareness about vacci-
nation. Many of the reasons that were reported are not about
people being un-informed, or even misinformed. Our literature
review reports ‘distrust of doctors’, ‘distrust of government sour-
ces’, and ‘distrust of pharmaceutical companies’ as reason for hes-
itancy. In the Netherlands, people who report such reasons are not
only vaccine-hesitant, but are also strongly associated with
rejecting vaccination outright (Zijtregtop et al., 2009). This helps to
explain why many hesitant attitudes are harboured by the well-
educated (Hak et al., 2005), and why few people express hesi-
tancy because they lack information about vaccination (Only 13% of
over 400 survey respondents felt they did not have access toian interactions.
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mation (Gust et al., 2008)).
Third, our consolidated evidence base suggests that under-
standing vaccination attitudes requires incorporating institutional
trust into models of information, communication and cognition
more explicitly. There may exist a wide variety of information
sources that shape vaccination attitudes but they are not all treated
equally by the general population. People visit sources they trust,
and attitudes are shaped accordingly. Both the literature and mar-
ket research data conﬁrmed that advice from healthcare pro-
fessionals was the main and most inﬂuential source of vaccination
information for most people. The pivotal role of the physiciane as a
trusted arbitrator of knowledge e is well recognised, but it remains
important for understanding hesitant attitudes. It is not vaccines
per se that are mistrusted, rather it is the institutions (through
which information about vaccines is delivered) that are mistrusted.
Information does not always speak for itself and social context
shapes how information is interpreted and used (Brown and
Duguid, 2002). As such, information in itself is not as important
as the institutions involved in its curation and delivery (Johns,
1998).
In our ﬁndings, the credibility of institutions seems to matter
more than the information content itself. A Dutch study we
reviewed found 83% of parents of non-vaccinated children believed
that ‘[t]he government is strongly inﬂuenced by the vaccine pro-
ducers’ (Gefenaite et al., 2012). Moreover, 56% of parents of non-
vaccinated children believed that the government would not
cease vaccinations if there was evidence of serious side effects.
Many parents of vaccinated children also shared these beliefs.
Whilst better information provision may improve vaccination at-
titudes in some cases, this is unlikely to be sufﬁcient in cases where
the institutions are mistrusted. Indeed counter-claims and refuta-
tions may make matters worse on internet forums where institu-
tional mistrust remains by serving to galvanise movements and
exacerbate polarisation of attitudes (Betsch and Sachse, 2012;
Sunstein, 2001).
Our results show the internet is used frequently as a source of
vaccination information. However, some websites were more
trusted than others, with government websites preferred over
blogs and Wikipedia. The appearance of friends, family and col-
leagues’ endorsement as a frequent reason for supporting vacci-
nation may seem less surprising if one assumes these sources are
increasingly trusted relative to other institutions e be it in person
or through social media. Even though they may not be ‘experts’ in
vaccination, they may provide welcome contrast to general infor-
mation intended for the population at large and may serve as local,
‘just-like-me’, reference points. Some parents put little emphasis
on science (McMurray et al., 2004), preferring instead to attach
high signiﬁcance to circumstantial and speciﬁc life events, incor-
porating their family history and religion, and their child’s birth
timing, maturity, allergies, sleep patterns and behaviour into their
attitudes about medicine and healthcare as a whole, not just
vaccination (Evans et al., 2001; Hobson-West, 2007; Poltorak et al.,
2005). The result is a particular view where each individual has his
or her own mix of risk factors and vulnerabilities. Mainstream
vaccination literature and the attitudes of physicians who don’t
take the time to familiarise themselves with personal narratives
can make patients feel the information they are receiving is irrel-
evant to their situations and concerns. For them, vaccine-critical
websites resonate strongly (Betsch et al., 2010) and sentiments
can travel quickly across ‘fertile’ social networks (UNICEF, 2013).
Fourthly, distrust in Eastern Europe takes a slightly different
form. In a Romanian study, many mothers declined HPV vaccina-
tion on the belief that the vaccination campaign was too experi-
mental and their daughters were being used as little more thantesting material (Craciun and Baban, 2012). Participants wondered
why else the vaccine would be available in Eastern Europe. Deliv-
ering the vaccine free of charge only exacerbated suspicions. Doc-
tors’ efforts at reassurance were seen to lack conviction in their
efforts to promote vaccination, their expertise regarding vaccines
was questioned, along with their impartiality from commercial
interests (pharmaceutical companies were also mistrusted). Where
participants had access to a trustworthy doctor (proxied by length
of time patient knew doctor and doctor’s expertise), the doctor’s
advice was reported as important in relation to accepting the
vaccine.
The ﬁndings discussed above are a static snapshot of vaccination
attitudes. There is preliminary evidence that the prevalence of
hesitancy and the challenges of addressing it are increasing over
time. Speciﬁc events, such as the ‘H1N1 pandemic’ and the
response to it, might exacerbate attitudes to vaccination by altering
trust in institutions. For example, in France, intention to refuse
pandemic inﬂuenza vaccination increased from 45% to 78% over the
last four months of 2009 (Chanel et al., 2011) and, in Greece, it
increased from 47% to 63% in August 2009 alone (Sypsa et al., 2009).
This is consistent with market research data (Fig. 8), showing that
fewer people report conﬁdence in vaccination since the ‘pandemic’.
Comparing market research data from 2004 to 2009, positive per-
ceptions of vaccination were reported less often in 2009. Market
research data also suggested that the challenges of establishing a
trustful relationship with patients may be worsening. Since 2004,
fewer GPs now report very positive perceptions and, compared to a
few years ago, about two-thirds of GPs report having to contend
withmore sceptical patients. However, it is important to emphasise
that this is a tentative ﬁnding which requires further evidence in
the form of direct pre- and post-2009 comparisons of vaccination
attitudes.
Some of these changes in attitude are likely to be part of broader
social and political transformations that are underway which, in
the literature we reviewed, tended to be overlooked. With
increasing rhetoric around ‘patient-choice’, public health agendas
have gradually shifted to accommodate the right to make an
informed choice and towards the primacy of an individual’s rights.
One indication of such a shift was apparent when, in the UK for
example, the response to lowered MMR vaccination uptake
neglected to prioritise any social beneﬁts of vaccination andmissed
the opportunity to present vaccination as a social duty (Hobson-
West, 2003).
The sense of empowerment that comes with taking re-
sponsibility over personal health means that those who trust (with
blind faith) generalised advice from authority can be viewed
disparagingly. The good parent becomes one who is a critical con-
sumer of health services and products, accounting for their own
individual situation as they see it with little regard for the impli-
cations of their decisions on other children (Hobson-West, 2007;
Poltorak et al., 2005). Indeed, one paper we reviewed reported
that parents felt vaccination was unnecessary if others in the vi-
cinity were vaccinated.
To a certain extent, the task is one of pointing out obligations to
others in society. This seems to be occurring in a rather haphazard
and uncoordinated way on peer-to-peer websites such as ‘mums-
net’ where some non-vaccinators are criticised for their lack of
social duty, for free-riding and for exposing unborn children to
diseases like rubella (Skea et al., 2008). Our review showed rela-
tively few citations to ‘protection of others’, suggesting an under-
appreciation of vaccination to wider society.
Blume (2006: 639) asks, “Isn’t a critical stance towards vacci-
nation a logical consequence of this ideological shift [towards
encouraging individual rights]?” The implication for those seeking
to create active demand for vaccination by articulating the common
Fig. 8. Changes in attitudes to vaccination (datasets 1 and 3).
O. Yaqub et al. / Social Science & Medicine 112 (2014) 1e118good is that they are likely to continue encountering tension from
efforts to encourage individual rights. Building active demand at
the community level may be even more challenging than building
active demand at the individual level.
4.2. Healthcare professionals face difﬁculties in building trust with
patients
Healthcare professionals report at least three challenges in
building a trustful relationship with patients. Firstly, a lack of time
with patients hindered recommendation of vaccination; as one
participant stated, “you just cannot do it all; it is a matter of making
choices” (Mollema et al., 2012). Even in a study of physicians’ at-
titudes where 90% agreed that the responsibility for ensuring
vaccination lay with healthcare professionals, “insufﬁcient time
with patients” was often cited as a reason why vaccination was not
recommended (McCarthy et al., 2012). As health professionals
operate under increasing time constraints, there is a growing op-
portunity for ‘alternative’medical information and practices to play
a more trusted role. Complementary and alternative medicine
(CAM) users refused vaccination more frequently than non-CAM
users (p < 0.001) (Zuzak et al., 2008). Many physicians can
become frustrated and respond simply by discontinuing care for
families that are non-compliant with vaccination (Flanagan-Klygis
et al., 2005). Outright dismissal of patients is unlikely to persuade
and instil conﬁdence (Freed et al., 2004). The physician not only
needs to keep abreast of the latest vaccine information but also
needs to remain engaged with seemingly random and unusual
patient concerns such as, for example, whether a parent considers
their child more likely to take up smoking following HPV vaccina-
tion (Casper and Carpenter, 2008; Waller et al., 2006).
Secondly, our results showed that healthcare professionals can
suffer from a lack of awareness about national guidelines and a lack
of knowledge about vaccines (both on speciﬁc attributes such as
beliefs about contraindications, as well as more general attributes
such as beliefs about vaccine-related allergies) (see also Betsch and
Wicker, 2012). Even where health professionals are informed, they
may not necessarily feel conﬁdent. In a study of Swedish midwives’attitudes to HPV vaccination, many felt uncertain about their
knowledge of HPV, despite receiving HPV information (Oscarsson
et al., 2011). They questioned their own competence to deliver
advice and answer questions effectively. A focus group with Dutch
healthcare professionals revealed that poorly communicated
changes in the national vaccination schedule and changes in sci-
entiﬁc understanding can exacerbate feelings of uncertainty
(Mollema et al., 2012). This lack of conﬁdence in dispensing advice
is likely to hinder the development of a trusting relationship.
Thirdly, healthcare professionals may have their own reserva-
tions about recommending speciﬁc vaccinations. Epistemic com-
munities can be large and the institutional arrangements for
discussing uncertainties can be intimidating (Knorr-Cetina, 1999),
some healthcare professionals may need support on how to navi-
gate these so that their vaccination recommendations are less
affected by their own personal positions and misperceptions. Ex-
amples of uncertainties that need to be discussed include safety,
potential beneﬁts, and alternatives. Regarding safety, participants
in two different studies were concerned about the long-term ef-
fects of the HPV vaccine, given that it has only been tested in what
they felt were ‘short’ studies (Gottvall et al., 2011; Oscarsson et al.,
2011). Regarding potential beneﬁts, many healthcare professionals
were critical of vaccination programmes when they perceived little
signiﬁcant disease burden reduction (Mollema et al., 2012).
Regarding alternatives and potential drawbacks, a majority of
Swedish midwives and nurses felt that the HPV vaccination may
undermine pre-existing cervical cancer-screening programs and
they even felt vaccination could encourage promiscuity or risky
sexual behaviour (Oscarsson et al., 2011). Such concerns, however
unsubstantiated or incorrect they may be, seem unlikely to be
alleviated unless there is a participatory approach to knowledge
and vaccination policy. Training should afford the opportunity to
engagewith the professionalised institutions inwhich such debates
occur and policy decisions are made.
Our results showed that healthcare professionals were not very
concerned with their own vaccination and were complacent about
contracting illness. These reasons seem more important in
explaining their non-vaccination than practical barriers which
O. Yaqub et al. / Social Science & Medicine 112 (2014) 1e11 9included a lack of time (cited twice), forgetting to vaccinate, and
missing the vaccination day at the hospital. Concerns about safety
also entered their attitudes towards self-vaccination, though there
is evidence to suggest that they probably perceive adverse events
less severely than the general population does (less than 4% of
healthcare professionals believed inﬂuenza vaccines had a ‘devas-
tating effect on the immune system’) (Socan et al., 2013; Wicker
et al., 2012).
4.3. Limitations
In both the literature and market research data, reasons for at-
titudes are self-reported rather than revealed or observed. Re-
spondents may not be able to articulate their reasons or even know
what they are, or they may have been prompted into offering rea-
sons they believed questioners wanted to hear. The results (Figs. 3e
5) only report the frequency with which various reasons for
vaccination attitudes are cited in the literature; no attempt was
made to quantitatively weight the reasons according to signiﬁcance
or importance (though this was done qualitatively in the discus-
sion). As such, the results of the literature review are subject to
publication biases that might exist in the literature. Some of the
results for a given population are drawn from a small number of
papers and where paper numbers are large, the complexity of
reasons can limit synthesis. There may be some differences in at-
titudes for different vaccines and countries which we did not have
scope to report here.
5. Conclusions and policy implications
Hesitant attitudes were prevalent in the empirical studies and
datasets we reviewed, and included people who had not yet
rejected vaccination. Focussing only on vaccine uptake rates and
neglecting underlying attitudes is likely to underestimate the
challenge of maintaining vaccination coverage in the future and is
likely to take future research in a less fruitful direction.
Emphasis on vaccine rejection steers research into under-
standing the behavioural characteristics of individuals who fail to
comply, which in turn drives recommendations towards targeting
efforts to ﬁght misinformation on certain deviant types of in-
dividuals. In contrast, emphasis on underlying attitudes gives rise
to a new research agenda, one that goes beyond notions of vaccine
acceptance such that it includes knowledge of communities,
knowledge about how they relate and trust the institutions
involved with vaccination and knowledge of how much active de-
mand there is for vaccination at the community level. Efforts to
measure trust in overall health systems are pertinent, but they
remain focused on how individuals rather than communities view
health systems (Ozawa and Sripad, 2013). Such community-level
data on active demand would also help public health authorities
ﬁnd greater legitimacy when they formulate ‘evidence-based’
policy (Roalkvam et al., 2013: p203) and when they call for further
rounds of vaccine innovation (Yaqub and Nightingale, 2012).
The EU Council’s conclusions on childhood vaccination, which
calls for the ECDC to monitor attitudes more closely and develop
new metrics, are highly germane. A network of sentinels across
Europe could be fruitful, particularly if its major task is to capture
vaccine speciﬁc concerns, geographical trends, and differences in
populations.
A wide variety of reasons were reported for vaccination atti-
tudes, few of which related to a lack of awareness or misinforma-
tion. Our consolidated evidence base suggested that understanding
vaccination attitudes requires incorporating institutional trust into
models of information. Whilst it is evident that people draw on an
increasingly wide range of information sources to shape theirvaccination attitudes, our paper found sharp differentiation in the
levels of trust and conﬁdence accorded to these various sources. For
many people, ‘ofﬁcial’ sources were already seen as having been
sullied by commercial interests or overzealous vaccinators. This
means that, in addition to developing new metrics and monitoring
them, restoring trust and credibility of the institutions involved
with vaccinations must take centre-stage.
As part of the effort to restore trust and credibility in institutions
involved with vaccination, the EU and national authorities need to
consider not only their own relationship with the public, but also
the support they offer healthcare professionals. Physicians are the
main and most inﬂuential source of vaccination information, but in
our review they reported facing increasing difﬁculties in building
trustful relationships with patients. Physicians now contend with
an increasing number of sceptical patients, whilst also being faced
with a lack of time for building relationships with patients. If this
continues unabated, the scope for opportunistic ‘alternative’ sour-
ces of information to be seen as trustworthy is likely to grow. Our
paper found that many physicians felt there was not enough sup-
port from governments and health authorities, and wanted better
vaccination campaigns.
A more pro-active stance from public institutions involved with
vaccination would be welcomed by most stakeholders, but
responding with more information campaigns is likely to be
insufﬁcient for building trust; for trust-building, more engagement
and interaction is needed. Institutions involved with vaccination
may take note of the inﬂuence of online social networks and try to
build further ‘online social presence’ or try to highlight the costs of
mistrust and suspicion (i.e. more illness); but the impact of such
efforts are likely to remain dependent on how trusted they are to
begin with. Such efforts need to be allied with other online and
ofﬂine platforms that draw in healthcare professionals and medical
societies to support sustained dialogue with hesitant patients.
Through engagement and dialogue, perhaps institutions will one
day make the notion of herd immunity as ubiquitous in everyday
health conversations as the notion of patient-choice has recently
become.
The paper showed that concern about safety underpinned most
hesitant attitudes. The way in which safety concerns develop into
overall hesitancy and rejection is likely to be affected by systems for
monitoring what happens after vaccination, for reporting any
adverse reactions and for engaging with post-vaccination anxieties
(Calain 2006, cited in Roalkvam et al., 2013). Where such systems
are not available, frustrations are more likely to be expressed
among friends or through the internet and other media, where the
scope for shifting attitudes is perhaps narrower. Further investi-
gation into vaccine safety surveillance systems (including active
surveillance studies) will help improve our understanding about
what institutional features sustain conﬁdence in vaccine safety
over the long term. This may also help avoid raising expectations
that vaccines should be 100% effective and safe.
Our paper also suggested that the some assumptions regarding
the design of teaching curricula and training programmes of
healthcare professionals may need examining. Curricula and
training programmes may assume that healthcare professionals
will (a) readily understand and support vaccination with minimal
introduction and will not need to subsequently revisit the topic in
their continual professional development, and (b) have the skills to
improve attitudes to vaccination among the general population
effectively. For example, unassertive physicians might beneﬁt from
acquiring skills from assertive physicians before attempting to
persuade and garner trust in hesitant patients. Where healthcare
professionals feel inhibited due to personal reservations, they may
need to be alerted to the mechanisms that exist for debating un-
certainties about vaccines and vaccination policy, offering them
O. Yaqub et al. / Social Science & Medicine 112 (2014) 1e1110support in accessing wider bodies of professional knowledge and
expertise.
Restoring trust in institutions is a multi-stakeholder problem.
Policy-makers must not shy away from the scale of engagement
needed with healthcare professionals and other stakeholders
whilst navigating notions such as patient-choice and the common
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